GetTopicDetailResponse(id=c330123238a6, topicName=TAK-071, introduction=, content=帕金森病 認(rèn)知障礙 TAK-071, image=null, comments=0, allHits=384, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Jan 12 15:58:12 CST 2025, time=2025-01-12, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=500338, tagList=[TagDto(tagId=500338, tagName=TAK-071)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2270729, encodeId=30b322e072901, content=<a href='/topic/show?id=46844850863' target=_blank style='color:#2F92EE;'>#帕金森#</a> <a href='/topic/show?id=c330123238a6' target=_blank style='color:#2F92EE;'>#TAK-071#</a>, objectTitle=JAMA Neurology：創(chuàng)新藥TAK-071在帕金森患者中的安全性與認(rèn)知改善效果, objectType=article, longId=884086, objectId=f2eb8840869d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-using-smartphone-app-in-hospital-office-PEMB8JL.jpg, objectUrl=/article/show_article.do?id=f2eb8840869d, replyNumber=0, likeNumber=29, createdTime=2025-06-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f2eb8840869d, moduleTitle=JAMA Neurology：創(chuàng)新藥TAK-071在帕金森患者中的安全性與認(rèn)知改善效果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f2eb8840869d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247705, encodeId=fb55224e705ce, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a> <a href='/topic/show?id=1507912e609' target=_blank style='color:#2F92EE;'>#認(rèn)知障礙#</a> <a href='/topic/show?id=c330123238a6' target=_blank style='color:#2F92EE;'>#TAK-071#</a>, objectTitle=JAMA Neurology：正變構(gòu)調(diào)節(jié)劑（TAK-071）在伴有認(rèn)知障礙的帕金森病患者中的應(yīng)用, objectType=article, longId=858952, objectId=6d66858952e7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/an-elderly-patient-at-the-hospital-PT6KR2Z.jpg, objectUrl=/article/show_article.do?id=6d66858952e7, replyNumber=0, likeNumber=54, createdTime=2025-01-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=6d66858952e7, moduleTitle=JAMA Neurology：正變構(gòu)調(diào)節(jié)劑（TAK-071）在伴有認(rèn)知障礙的帕金森病患者中的應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6d66858952e7)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-01-12發(fā)表于陜西省
